Acute Admissions Rates for Lung Cancer Patients Up During Pandemic, Not Linked to COVID-19
Data from a single-center study in Scotland suggested that there were more patients with lung cancer admitted acutely with cancer, non-COVID-19-related illness during the COVID-19 pandemic. “Early and late lockdown […] Read more
Modeling Analyses Show That Expansions in Lung Cancer Screening Guidelines to Better Capture Underrepresented Populations Still Need Work
Kara Nyberg, PhDTwo abstracts presented at the 2020 World Conference on Lung Cancer shed light on how changes in current screening guidelines can influence lung cancer detection rates, specifically among underrepresented populations. […] Read more
Young Investigators Awarded Grants to Study COVID-19 and Lung Cancer
Lung Ambition Alliance to award four new Junior Faculty Research Grants. Four early-career researchers have been selected to receive the Lung Ambition Alliance Junior Faculty Grants for the Study of […] Read more
The IASLC has formed an alliance with the Global Lung Cancer Coalition (GLCC), Guardant Health, and AstraZeneca to accelerate the pace of lung cancer survival worldwide. This collaborative effort—known as […] Read more
Use of Predictive Biomarkers, Incorporating Chemotherapy—What Is Best When Using Immunotherapy in Advanced NSCLC?
Kara Nyberg, PhDOncologists currently have three main therapeutic strategies to choose from when managing patients with advanced NSCLC who lack targetable mutations: immunotherapy alone, immunotherapy-immunotherapy combinations, or immunotherapy-chemotherapy combinations. So how does […] Read more
Heather A. Wakelee, MD
Heather A. Wakelee, MD, has been promoted to Chief of the Division of Oncology at Stanford University. She has also assumed the role of Deputy Director of the Stanford Cancer […] Read more
Ming S. Tsao, MD, FRCPC, of the Princess Margaret Cancer Centre, Toronto, delivered a Plenary Presentation during the 2020 World Conference on Lung Cancer outlining key updates found in the […] Read more
Amivantamab for Exon 20-Related NSCLC: Excitement in the Patient Community We look forward to Dr. Joshua Sabari’s presentation during the oral abstract presentation session “OA04: new Data from Rare EGFR […] Read more
Comparing Patient-Reported Outcomes in the CROWN Study
ALK Positive Medical CommitteeThe abstract “Patient-reported outcomes from the randomized Phase 3 CROWN study of first-line lorlatinib versus crizotinib in ALK+ NSCLC” by Mazieres et al., presents a welcome analysis of symptoms and […] Read more
Palliative and end of life care discussions are significant and essential, yet sensitive and challenging. Cultural perceptions of pain and end of life can filter nuances in provider communication in […] Read more